Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Papers: 17 Jul 2015 - 24 Jul 2015
Pharmacoeconomic Aspects of Multiple Sclerosis Treatments in Iran.
Astrocyte tissue factor controls CNS hemostasis and autoimmune inflammation.
Quality of Life Among Patients with Multiple Sclerosis Treated with Prolonged-Release Fampridine 10 Mg Tablets for Walking Impairment.
Papers: 11 Sep 2015 - 18 Sep 2015
Best Practices and Key Challenges in Cost-Effectiveness Modelling of Multiple Sclerosis Therapies.
Cortical functional modifications following optic neuritis.
Cross-disease transcriptomics: Unique IL-17A signaling in psoriasis lesions and an autoimmune PBMC signature.
Pediatric Optic Neuritis Prospective Outcomes Study.
Susac's syndrome: Leptomeningeal enhancement on 3D FLAIR MRI.
Biotinidase deficiency mimicking neuromyelitis optica beginning at the age of 4: A treatable disease.
Sunshine, Sea, and Season of Birth: MS Incidence in Wales.
Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported.
Does Current Portuguese Financing Model for Multiple Sclerosis Covers for Estimated Needs?
Further Understanding of the Immunopathology of Multiple Sclerosis: Impact on Future Treatments.
Co-stimulatory and Co-inhibitory Pathways in Autoimmunity.
25 Hydroxyvitamin D and Cytokines in Multiple Sclerosis.
ERβ in CD4+ T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity.
Episode 80 with Dr. Kaarina Kowalec on adverse MS drug reactions
Information processing speed in multiple sclerosis: Past, present, and future.
Mucocele After Orbital Fracture Repair Masquerading as Optic Neuritis.
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis.
Cost-Effectiveness of Subcutaneous Interferon Beta-1A in a Sub-Population of Multiple Sclerosis Patients (Kurtzke Expanded Disability Status Scale [EDSS]: >3.5-5.0).
Improving Clinical Outcomes and Health Care Resources Utilization in Multiple Sclerosis: A Portuguese Hospital Perspective.
The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.
Pages
« first
‹ previous
…
29
30
31
32
33
34
35
36
37
…
next ›
last »